Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Matthieu Rouanne"'
Autor:
Jason A. Efstathiou, Maria J. Ribal, Yann Neuzillet, Antoine G. van der Heijden, Richard Cathomas, Matthieu Rouanne, Nigel C. Cowan, Rainer Fietkau, Harman Maxim Bruins, Anja Lorch, Erik Veskimäe, Estefania Linares Espinós, J. Alfred Witjes, Virginia Hernández, Georgios Gakis, Matthew I. Milowsky, Eva Compérat, George N. Thalmann
Publikováno v:
European Urology, 81, 95-103
European Urology, 81, 1, pp. 95-103
European Urology, 81, 1, pp. 95-103
Contains fulltext : 248305.pdf (Publisher’s version ) (Closed access) CONTEXT: Treatment of metastatic urothelial carcinoma is currently undergoing a rapid evolution. OBJECTIVE: This overview presents the updated European Association of Urology (EA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aafcdd1b5d953f268b8e13859ba9784b
https://doi.org/10.1016/j.eururo.2021.09.026
https://doi.org/10.1016/j.eururo.2021.09.026
Autor:
Marc Hilmi, Natacha Naoun, Alice Boilève, Arthur Géraud, Arnaud Bayle, Arnaud Pagès, Marion Aupomerol, Matthieu Rouanne, François-Xavier Madec, Fanny Pommeret, Christophe Massard, Capucine Baldini, Florian Scotté, Stéphane Champiat
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 30(12)
Patients enrolled in oncology phase 1 trials (ph1) usually have advanced heavily pre-treated cancers with few therapeutic options. Quality of life (QoL) is one of the key cancer-treatment outcome measures, especially in ph1, and sexuality is an impor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26f298d963b86f211a22a17bdd9549f5
https://pubmed.ncbi.nlm.nih.gov/36271944
https://pubmed.ncbi.nlm.nih.gov/36271944